Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
Authors:
Open Access
- 27 February 2014
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 5 (2) , e1094
Abstract
MYOGENIN is a member of the muscle regulatory factor family that orchestrates an obligatory step in myogenesis, the terminal differentiation of skeletal muscle cells. A paradoxical feature of alveolar rhabdomyosarcoma (ARMS), a prevalent soft tissue sarcoma in children arising from cells with a myogenic phenotype, is the inability of these cells to undergo terminal differentiation despite the expression of MYOGENIN. The chimeric PAX3-FOXO1 fusion protein which results from a chromosomal translocation in ARMS has been implicated in blocking cell cycle arrest, preventing myogenesis from occurring. We report here that PAX3-FOXO1 enhances glycogen synthase kinase 3β (GSK3β) activity which in turn represses MYOGENIN activity. MYOGENIN is a GSK3β substrate in vitro on the basis of in vitro kinase assays and MYOGENIN is phosphorylated in ARMS-derived RH30 cells. Constitutively active GSK3β(S9A) increased the level of a phosphorylated form of MYOGENIN on the basis of western blot analysis and this effect was reversed by neutralization of the single consensus GSK3β phosphoacceptor site by mutation (S160/164A). Congruently, GSK3β inhibited the trans-activation of an E-box reporter gene by wild-type MYOGENIN, but not MYOGENIN with the S160/164A mutations. Functionally, GSK3β repressed muscle creatine kinase (MCK) promoter activity, an effect which was reversed by the S160/164A mutated MYOGENIN. Importantly, GSK3β inhibition or exogenous expression of the S160/164A mutated MYOGENIN in ARMS reduced the anchorage independent growth of RH30 cells in colony-formation assays. Thus, sustained GSK3β activity represses a critical regulatory step in the myogenic cascade, contributing to the undifferentiated, proliferative phenotype in alveolar rhabdomyosarcoma (ARMS).Keywords
This publication has 45 references indexed in Scilit:
- Krüppel-like factor 6 (KLF6) promotes cell proliferation in skeletal myoblasts in response to TGFβ/Smad3 signalingSkeletal Muscle, 2013
- Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cellsOncogene, 2012
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivoCell Death & Differentiation, 2011
- MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated stateGenes & Development, 2009
- Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2DMolecular and Cellular Biology, 2008
- p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiationNature Structural & Molecular Biology, 2007
- PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1Proceedings of the National Academy of Sciences, 2007
- Functional Interdependence at the Chromatin Level between the MKK6/p38 and IGF1/PI3K/AKT Pathways during Muscle DifferentiationMolecular Cell, 2007
- Smad7 Promotes and Enhances Skeletal Muscle DifferentiationMolecular and Cellular Biology, 2006
- Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin geneNature, 1993